Skip to content
DataLookout
Start free
Menu

NCT00804583

Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

See at-risk trials from University of North Carolina, Chapel Hill

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 26 versions: 19 with changes below, 7 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 2027 to Jul 2028
    • Eligibility criteria expanded, about 9 words
    • Study description revised
    • Publications: details revised at 10 of 11 entries
  2. Primary and study completion dates: Jul 2026 to Jul 2027v25
  3. Primary and study completion dates: Jul 2024 to Jul 2026v24
  4. Primary and study completion dates: Jul 2023 to Jul 2024v23
  5. Primary and study completion dates: Jul 2022 to Jul 2023
    • Publications: 9 to 11
    v22
Show 13 earlier versionsHide 13 earlier versions
  1. Primary and study completion dates: Jul 2021 to Jul 2022v21
  2. Primary and study completion dates: Jul 2019 to Jul 2021v19
  3. Primary and study completion dates: Jul 2018 to Jul 2019
    • Publications: 8 to 9
    • Study description expanded, about 1 word
    v18
  4. Primary and study completion dates: Jul 2017 to Jul 2018v16
  5. Primary and study completion dates: Jul 2016 to Jul 2017v15 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 500 to confirmed 154
    • Site details revised
    • Publications: 7 to 8
  6. Primary and study completion dates: Jul 2015 to Jul 2016v12
  7. Publications: 4 to 7v11
  8. Study Status, Outcome Measuresv9
  9. Primary and study completion dates: Mar 2012 to Jul 2015v7
  10. Primary and study completion dates: Mar 2011 to Mar 2012v5
  11. Primary and study completion dates: Mar 2010 to Mar 2011
    • Collaborators: 1 to 2
    • Publications expanded, about 247 words
    v4
  12. Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to University of North Carolina, Chapel Hill
    • Collaborators expanded, about 10 words
    v3
  13. Primary and study completion dates: Feb 2009 to Mar 2010v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

This is not an interventional study
Timeframe: One Year

Sites

1 site in 1 country

  • The University of North Carolina at Chapel HillChapel Hill, North Carolina, United States